Ovarian cancer clinical trials
927 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all ovarian cancer studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting ovarian cancer studies. A study counts once in each state where it has a site.
- Texas184
- California150
- New York147
- Florida127
- Ohio104
- Pennsylvania103
- Massachusetts94
- Virginia94
- Tennessee83
- Michigan80
- Minnesota77
- Illinois73
Also in China (203), France (111), Italy (102), Spain (88), United Kingdom (70), Australia (67), Canada (66), South Korea (66).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 112
- Phase 1146
- Phase 1 / Phase 2111
- Phase 2152
- Phase 2 / Phase 312
- Phase 364
- Phase 49
- No phase (devices, programs)192
- Observational229
Recently updated studies
Recruiting ovarian cancer studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingPhase 1NCT07705035
DBC-664 in Adult Patients With Solid Tumors
Ages 18 Years and over · Denver, Colorado · Grand Rapids, Michigan +5 more · Duboce Biopharmaceuticals, Inc.
- RecruitingObservationalNCT07896421
Real-World Study of Mirvetuximab Soravtansine in Adult Participants With Platinum-Resistant FRα-Positive Ovarian, Fallopian Tube, and Peritoneal Cancer
Ages 18 Years and over · Vienna, Austria · AbbVie
- RecruitingPhase 1 / Phase 2NCT07446855
Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours
Ages 18 Years – 130 Years · New York, New York · Providence, Rhode Island +14 more · AstraZeneca
- RecruitingNo phase (devices, programs)NCT06466382
OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
Ages 18 Years and over · Baden, Canton of Aargau · Basel, Canton of Basel-City +8 more · Swiss GO Trial Group
- RecruitingNo phase (devices, programs)NCT07896642
Brown Adipose Tissue Modulation in Polycystic Ovary Syndrome Using Infrared Thermography
Ages 18 Years – 40 Years · Istanbul, Turkey (Türkiye) · Istanbul Health and Technology University
- RecruitingPhase 1NCT07213791
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Ages 18 Years and over · Newport Beach, California · Stanford, California +24 more · Eli Lilly and Company
- RecruitingObservationalNCT07896772
Anti-Müllerian Hormone in Breast Cancer Clinical Practice
Ages 20 Years – 55 Years · Brno, Czechia · Masaryk Memorial Cancer Institute
- RecruitingPhase 1NCT05950464
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Ages 18 Years and over · Augusta, Georgia · Chicago, Illinois +9 more · National Cancer Institute (NCI)
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.